Figure 6.
Comparative resistance profiles of Efavirenz (EFZ), Nevirapine (NVP), Delavirdine (DLV), Etravirine (ETR) and DAVP-1 towards four NNRTI-associated RT mutants. Red squares stand for strong loss of activity (>5-fold change), orange for intermediate loss of activity and green for weak loss of activity (<2-fold change).